Navigation Links
Pathogenica CSO Speaks at IBC Life Sciences Drug Discovery & Diagnostic Development Week
Date:8/2/2011

CAMBRIDGE, Mass., Aug. 2, 2011 /PRNewswire/ -- Pathogenica, Inc. announced that the Company's Chief Scientific Officer, Graeme Doran, Ph.D., is speaking today at the IBC Life Sciences Drug Discovery & Diagnostic Development Week, in San Francisco.

During the conference, the only event on the application of next generation sequencing technology for research, diagnostic development, and patient care, Dr. Doran will speak on "Next Generation Sequencing & Genomic Medicine." He will present the development of Pathogenica's next generation sequencing assays for clinical diagnostics for greater accuracy at reduced cost. He will focus on Pathogenica's Human Papillomavirus sequencing panel, and demonstration of HPV identification from ThinPrep clinical samples.

"This is a significant demonstration of the utility of our assay for clinical specimens in combination with NGS," said Yemi Adesokan, Ph.D., Pathogenica's CEO. "Our work so far demonstrates that NGS can be applied to routine HPV screening specimens to precisely identify viral sub-types relevant to therapeutic decision-making. The Pathogenica DxSeq probe panels achieve comprehensive coverage of >30 high and low risk HPV strains from a single assay."

The Pathogenica test identified the presence of several HPV sub-types amongst the samples tested (HPV 16, 18, 31, 45, 51, 52, 56, 58, 67, 68, 97), and was able to identify multiple strains infecting a single individual. HPV plays a causative role in a number of cancers, and multiple infections may be of clinical significance and correlate with higher-grade lesions. Sequencing's ability to rapidly identify and quantify multiple infections is a significant advantage for clinicians to understand the impact of these viral subtypes.

In his talk, Dr. Doran will also preview forthcoming clinical applications of next generation sequencing for viral and bacterial genotyping.

Dr. Doran received undergraduate and D.Phil degrees from the University of Oxford, and has worked as a postdoctoral scientist on non-coding RNA biology and RNA sequencing at the David H. Koch Center for Integrative Cancer Research at MIT, and the Department of Pathology, Harvard Medical School. He has contributed book chapters, multiple peer-reviewed publications, presentations at international conferences, and currently serves as associate editor for the Journal of RNAi and Gene Silencing, and the Journal of Molecular and Genetic Medicine. He joined Pathogenica in 2010.

Pathogenica is preparing for CLIA approval and a commercial launch of its diagnostic tests in 2012.

About Pathogenica

Pathogenica, based in Cambridge, MA, was founded in 2009 to pioneer commercial applications of pathogen sequencing. Pathogenica applies next generation DNA sequencing technology for rapid multiplex identification of pathogens, drug resistance genes, and toxins in patient samples. The founding scientific advisory board (SAB) is comprised of distinguished scientists in the field, including George Church, Harvard Medical School; Ron Davis, Stanford University; W. Ian Lipkin, Columbia University; Andrew Onderdonk, Harvard Medical School; and Kun Zhang, University of California.

Pathogenica's high throughput pathogen detection system is expected to enable rapid and highly sensitive detection of a wide variety of pathogens from patient samples using just a common assay protocol. http://www.pathogenica.com

Contact:
Daniel Jackson
908-433-2628
djackson[at]pathogenica.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Pathogenica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference
2. Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India
3. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
4. Patent Attorney John Rizvi Speaks at FIME International Medical Expo
5. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
6. Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at Persuasive Technologies 2009 Conference and Voices That Matter Web Design Conference
7. Professor K. C. Nicolaou Speaks at WuXi AppTec
8. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
9. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
10. Neurocrine Biosciences Reports Second Quarter 2011 Results
11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Frederick Innovative Technology Center, Inc. (FITCI), a business ... start-ups, is hosting “Celebration Friday” (a festive gathering highlighting client success stories) and ... networking at 3:30 p.m. at FITCI’s 4539 Metropolitan Court location, off English Muffin ...
(Date:4/20/2017)... ... April 20, 2017 , ... As ... webinar will explore challenging patient cases when screening for direct oral anticoagulant. When ... be a need for bridging parental anticoagulation especially for those at high risk ...
(Date:4/20/2017)... 2017  Eli Lilly and Company (NYSE: ... for the prevention of migraine at the American Academy ... April 22-28, 2017, in Boston . ... AAN, including safety and patient outcomes data for galcanezumab ... reduction in monthly migraine headache days among patients with ...
(Date:4/20/2017)... ... April 20, 2017 , ... Husson University will be ... growing body of knowledge during its Eighth Annual Research and Scholarship Day ... Darling Atrium. During the event, undergraduates, graduate students, and faculty members from all ...
Breaking Biology Technology:
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):